Nalaganje...
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
BACKGROUND: Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by arterial or venous thrombosis (or both), and/or pregnancy morbidity in association with the presence of antiphospholipid antibodies. The prevalence of APS is estimated at 40 to 50 cases per 100,000 people....
Shranjeno v:
| izdano v: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2020
|
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094585/ https://ncbi.nlm.nih.gov/pubmed/33045766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012169.pub3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|